Ren Qing-Shuai, Sun Qiu, Cheng Shu-Qin, Du Li-Ming, Guo Ping-Xuan
Department of Cardiovascular Surgery, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, Hebei Province, China.
Department of Hepatobiliary, Kailuan General Hospital, Tangshan 063000, Hebei Province, China.
World J Gastrointest Oncol. 2024 Jun 15;16(6):2571-2591. doi: 10.4251/wjgo.v16.i6.2571.
Hepatocellular carcinoma (HCC) is a global popular malignant tumor, which is difficult to cure, and the current treatment is limited.
To analyze the impacts of stress granule (SG) genes on overall survival (OS), survival time, and prognosis in HCC.
The combined The Cancer Genome Atlas-Liver Hepatocellular Carcinoma (TCGA-LIHC), GSE25097, and GSE36376 datasets were utilized to obtain genetic and clinical information. Optimal hub gene numbers and corresponding coefficients were determined using the Least absolute shrinkage and selection operator model approach, and genes for constructing risk scores and corresponding correlation coefficients were calculated according to multivariate Cox regression, respectively. The prognostic model's receiver operating characteristic (ROC) curve was produced and plotted utilizing the time ROC software package. Nomogram models were constructed to predict the outcomes at 1, 3, and 5-year OS prognostications with good prediction accuracy.
We identified seven SG genes (, , , , , , ) having a prognostic significance and developed a risk score model. The findings of Kaplan-Meier analysis indicated that the group with a high risk exhibited significantly reduced OS in comparison with those of the low-risk group ( < 0.001). The nomogram model's findings indicate a significant enhancement in the accuracy of OS prediction for individuals with HCC in the TCGA-HCC cohort. Gene Ontology and Gene Set Enrichment Analysis suggested that these SGs might be involved in the cell cycle, RNA editing, and other biological processes.
Based on the impact of SG genes on HCC prognosis, in the future, it will be used as a biomarker as well as a unique therapeutic target for the identification and treatment of HCC.
肝细胞癌(HCC)是一种全球流行的恶性肿瘤,难以治愈,目前的治疗方法有限。
分析应激颗粒(SG)基因对HCC患者总生存期(OS)、生存时间和预后的影响。
利用癌症基因组图谱-肝细胞癌(TCGA-LIHC)、GSE25097和GSE36376数据集的组合来获取遗传和临床信息。使用最小绝对收缩和选择算子模型方法确定最佳枢纽基因数量和相应系数,并分别根据多变量Cox回归计算构建风险评分的基因和相应的相关系数。利用时间ROC软件包生成并绘制预后模型的受试者工作特征(ROC)曲线。构建列线图模型以预测1年、3年和5年OS预后的结果,预测准确性良好。
我们鉴定出7个具有预后意义的SG基因(,,,,,,),并建立了一个风险评分模型。Kaplan-Meier分析结果表明,高风险组的OS与低风险组相比显著降低(<0.001)。列线图模型的结果表明,TCGA-HCC队列中HCC患者的OS预测准确性有显著提高。基因本体论和基因集富集分析表明,这些SGs可能参与细胞周期、RNA编辑和其他生物学过程。
基于SG基因对HCC预后的影响,未来它将作为一种生物标志物以及用于HCC识别和治疗的独特治疗靶点。